Womens Health | Medical Device
Fillergyn™ is a medical device in class IIA for the treatment of vaginitis atrophic produced and marketed by Omini Pharma, Fillergyn™ is a medical device in class IIA for the treatment of vaginitis atrophic produced and marketed by Omini Pharma,a small pharmaceutical Italian company, certified ISO 13485:2016. Fillergyn™ is a vaginal cream based on hyaluronic acid, MSN and TTO (patented formula). The effectiveness of the device in the treatment of atrophic vaginitis is validated by a rigorous clinical study on the marketed product. Fillergyn™ is marketed in Italy by in exclusive by one of biggest pharma, we are now looking for distributors for the EU and Extra UE markets.The Medical Device is available in two versions: a 5 ml single dose and a 25ml multidose with 7 single use applicators.
The result from Fillergyn™ Medical Device in the clinical trial at the University of Trieste (IRCS Burlo Garofolo, Trieste, Italy) showing an excellent efficacy and tolerability.
(Grimaldi EP et al. Role of high molecular weight Hyaluronic acid in postmenopausal vaginal discomfort. Minerva Ginecol. 2012; 64(5):1-7).
Clinical Trial | Medical Device